Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
50
DRUG Quote, Financials, Valuation and Earnings
Last price:
$82.24
Seasonality move
:
-32.54%
Day range:
$81.55 - $88.67
52-week range:
$23.18 - $97.75
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
10.85x
Volume:
188K
Avg. volume:
166.2K
1-year change:
104.38%
Market cap:
$639.5M
Revenue:
--
EPS (TTM):
-$1.24
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | $4.7K | $53.7K | $53.9K | $55K | |
| Gross Profit | -- | -$4.7K | -$53.7K | -$53.9K | -$55K | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $5M | $9.5M | $3.7M | $867.1K | $7.9M | |
| Selling, General & Admin | $829.9K | $806.3K | $295.3K | $224.6K | -- | |
| Other Inc / (Exp) | $121.9K | $8K | $10.5K | -$6.8K | -- | |
| Operating Expenses | $7M | $11.7M | $5.4M | $2M | $9.9M | |
| Operating Income | -$7M | -$11.7M | -$5.5M | -$2.1M | -$9.9M | |
| Net Interest Expenses | -- | -- | $14.6K | $6.6K | $25.6K | |
| EBT. Incl. Unusual Items | -$6.8M | -$11.7M | -$5.5M | -$2.1M | -$8.7M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$6.8M | -$11.7M | -$5.5M | -$2.1M | -$8.7M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$6.8M | -$11.7M | -$5.5M | -$2.1M | -$8.7M | |
| Basic EPS (Cont. Ops) | -$3.81 | -$4.74 | -$1.47 | -$0.48 | -$1.27 | |
| Diluted EPS (Cont. Ops) | -$3.81 | -$4.74 | -$1.47 | -$0.48 | -$1.27 | |
| Weighted Average Basic Share | $1.8M | $2.5M | $3.7M | $4.3M | $6.9M | |
| Weighted Average Diluted Share | $1.8M | $2.5M | $3.7M | $4.3M | $6.9M | |
| EBITDA | -$7M | -$11.7M | -$5.4M | -$2M | -$9.9M | |
| EBIT | -$7M | -$11.7M | -$5.5M | -$2.1M | -$9.9M | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -$7M | -$11.7M | -$5.5M | -$2.1M | -$9.9M | |
| Operating Income (Adjusted) | -$7M | -$11.7M | -$5.5M | -$2.1M | -$9.9M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | $4.6K | $13.5K | $13.9K | $12.3K | |
| Gross Profit | -- | -$4.6K | -$13.5K | -$13.9K | -$12.3K | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $1.8M | $1.9M | $813.6K | $305K | $3.5M | |
| Selling, General & Admin | $189.1K | $135.1K | $27.3K | $39.2K | -- | |
| Other Inc / (Exp) | $79.1K | $38.4K | $43.2K | $8.7K | -- | |
| Operating Expenses | $2.4M | $2.3M | $1.2M | $564.3K | $4.1M | |
| Operating Income | -$2.4M | -$2.3M | -$1.2M | -$578.2K | -$4.1M | |
| Net Interest Expenses | -- | -- | $2.8K | $1.9K | $5.3K | |
| EBT. Incl. Unusual Items | -$2.3M | -$2.3M | -$1.1M | -$567.1K | -$2.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | $187.2K | |
| Net Income to Company | -$2.3M | -$2.3M | -$1.1M | -$571.7K | -$3M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$2.3M | -$2.3M | -$1.1M | -$567.1K | -$3M | |
| Basic EPS (Cont. Ops) | -$0.96 | -$0.76 | -$0.30 | -$0.13 | -$0.41 | |
| Diluted EPS (Cont. Ops) | -$0.96 | -$0.76 | -$0.30 | -$0.13 | -$0.41 | |
| Weighted Average Basic Share | $2.4M | $3M | $3.8M | $4.5M | $7.2M | |
| Weighted Average Diluted Share | $2.4M | $3M | $3.8M | $4.5M | $7.2M | |
| EBITDA | -$2.4M | -$2.3M | -$1.2M | -$564.3K | -$4.1M | |
| EBIT | -$2.4M | -$2.3M | -$1.2M | -$578.2K | -$4.1M | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -$2.4M | -$2.3M | -$1.2M | -$578.2K | -$4.1M | |
| Operating Income (Adjusted) | -$2.4M | -$2.3M | -$1.2M | -$578.2K | -$4.1M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | $4.6K | $53.7K | $53.9K | $54.9K | |
| Gross Profit | -- | -$4.6K | -$53.7K | -$53.9K | -$54.9K | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $4.9M | $9.6M | $3.7M | $868.6K | $8M | |
| Selling, General & Admin | $837.7K | $809.6K | $329.2K | $217.8K | $565.4K | |
| Other Inc / (Exp) | $125.7K | $6.7K | $10.9K | -$6.9K | -- | |
| Operating Expenses | $7.1M | $11.7M | $5.4M | $2M | $9.9M | |
| Operating Income | -$7.1M | -$11.8M | -$5.5M | -$2.1M | -$10M | |
| Net Interest Expenses | -- | -- | $10.1K | $6.6K | $21K | |
| EBT. Incl. Unusual Items | -$7M | -$11.7M | -$5.5M | -$2.1M | -$8.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | $900 | |
| Net Income to Company | -$6.9M | -$11.7M | -$5.5M | -$2.1M | -$8.9M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$7M | -$11.7M | -$5.5M | -$2.1M | -$8.8M | |
| Basic EPS (Cont. Ops) | -$3.27 | -$4.76 | -$1.47 | -$0.50 | -$1.23 | |
| Diluted EPS (Cont. Ops) | -$3.27 | -$4.76 | -$1.47 | -$0.51 | -$1.24 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -$7.1M | -$11.7M | -$5.4M | -$2M | -$9.9M | |
| EBIT | -$7.1M | -$11.8M | -$5.5M | -$2.1M | -$10M | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -$7.1M | -$11.8M | -$5.5M | -$2.1M | -$10M | |
| Operating Income (Adjusted) | -$7.1M | -$11.8M | -$5.5M | -$2.1M | -$10M | |
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2026-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $4.6K | $53.7K | $53.8K | $54.8K | -- | |
| Gross Profit | -$4.6K | -$53.7K | -$53.8K | -$54.8K | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $9.6M | $3.7M | $868.6K | $8M | -- | |
| Selling, General & Admin | $809.5K | $329.1K | $217.8K | $565.4K | -- | |
| Other Inc / (Exp) | $6.7K | $10.9K | -$6.9K | $1.1M | -- | |
| Operating Expenses | $11.7M | $5.4M | $2M | $9.9M | -- | |
| Operating Income | -$11.8M | -$5.5M | -$2.1M | -$10M | -- | |
| Net Interest Expenses | -- | $10.1K | $6.6K | $21K | -- | |
| EBT. Incl. Unusual Items | -$11.7M | -$5.5M | -$2.1M | -$8.8M | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | $900 | -- | |
| Net Income to Company | -$11.7M | -$5.5M | -$2.1M | -$8.9M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$11.7M | -$5.5M | -$2.1M | -$8.8M | -- | |
| Basic EPS (Cont. Ops) | -$4.76 | -$1.47 | -$0.50 | -$1.23 | -- | |
| Diluted EPS (Cont. Ops) | -$4.76 | -$1.47 | -$0.51 | -$1.24 | -- | |
| Weighted Average Basic Share | $10.1M | $14.9M | $17.3M | $27.5M | -- | |
| Weighted Average Diluted Share | $10.1M | $14.9M | $17.5M | $27.9M | -- | |
| EBITDA | -$11.7M | -$5.4M | -$2M | -$9.9M | -- | |
| EBIT | -$11.8M | -$5.5M | -$2.1M | -$10M | -- | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -$11.8M | -$5.5M | -$2.1M | -$10M | -- | |
| Operating Income (Adjusted) | -$11.8M | -$5.5M | -$2.1M | -$10M | -- | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $15.6M | $8.5M | $5M | $4.2M | $59.6M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $132.8K | $119.7K | $20.5K | $160.4K | $710K | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $15.8M | $8.7M | $5M | $4.4M | $60.6M | |
| Property Plant And Equipment | -- | $101.1K | $49.1K | $87.1K | $80.5K | |
| Long-Term Investments | $26.6K | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $15.8M | $8.8M | $5.1M | $4.5M | $60.7M | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | $32.9K | $115.7K | $18.4K | $30.9K | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | $49.7K | $54.1K | $58.8K | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $504.1K | $1.1M | $207.7K | $391.3K | $1.7M | |
| Long-Term Debt | -- | $52.4K | -- | $29.3K | $29.6K | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $504.1K | $1.1M | $207.7K | $420.6K | $1.7M | |
| Common Stock | $21.4M | $23.5M | $25.1M | $26.2M | $88.6M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $15.3M | $7.7M | $4.9M | $4.1M | $59M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $15.3M | $7.7M | $4.9M | $4.1M | $59M | |
| Total Liabilities and Equity | $15.8M | $8.8M | $5.1M | $4.5M | $60.7M | |
| Cash and Short Terms | $15.6M | $8.5M | $5M | $4.2M | $59.6M | |
| Total Debt | -- | $101.8K | $54.4K | $88.1K | $90.4K | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $15.6M | $8.5M | $5M | $4.2M | $59.6M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $132.8K | $119.7K | $20.5K | $160.4K | $710K | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $15.8M | $8.7M | $5M | $4.4M | $60.6M | |
| Property Plant And Equipment | -- | $101.1K | $49.1K | $87.1K | $80.5K | |
| Long-Term Investments | $26.6K | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $15.8M | $8.8M | $5.1M | $4.5M | $60.7M | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | $32.9K | $115.7K | $18.4K | $30.9K | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | $49.7K | $54.1K | $58.8K | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $504.1K | $1.1M | $207.7K | $391.3K | $1.7M | |
| Long-Term Debt | -- | $52.4K | -- | $29.3K | $29.6K | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $504.1K | $1.1M | $207.7K | $420.6K | $1.7M | |
| Common Stock | $21.4M | $23.5M | $25.1M | $26.2M | $88.6M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $15.3M | $7.7M | $4.9M | $4.1M | $59M | |
| Total Liabilities and Equity | $15.8M | $8.8M | $5.1M | $4.5M | $60.7M | |
| Cash and Short Terms | $15.6M | $8.5M | $5M | $4.2M | $59.6M | |
| Total Debt | -- | $101.8K | $54.4K | $88.1K | $90.4K | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$6.8M | -$11.7M | -$5.5M | -$2.1M | -$8.7M | |
| Depreciation & Amoritzation | -- | $4.7K | $53.7K | $53.9K | $55K | |
| Stock-Based Compensation | $696.5K | $684.9K | $854.3K | $617.1K | $2.3M | |
| Change in Accounts Receivable | -$87.1K | -$35.7K | $88.1K | -$9.7K | -$259.5K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$5.8M | -$10.6M | -$5.2M | -$1.4M | -$6.2M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -$5.6K | -$63.8K | -$65.9K | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$1.4M | -$626.2K | -$20K | -- | -- | |
| Cash From Financing | $20.6M | $4.1M | $1.6M | $595.7K | $61.2M | |
| Beginning Cash (CF) | $15.5M | $8.4M | $4.9M | $4.2M | $59.5M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $15M | -$6.4M | -$3.6M | -$755.4K | $55.2M | |
| Ending Cash (CF) | $30.7M | $2.2M | $1.3M | $3.4M | $114.9M | |
| Levered Free Cash Flow | -$5.8M | -$10.6M | -$5.2M | -$1.4M | -$6.2M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$2.3M | -$2.3M | -$1.1M | -$571.7K | -$3M | |
| Depreciation & Amoritzation | -- | $4.7K | $13.5K | $14.1K | $12.6K | |
| Stock-Based Compensation | $298.8K | $22.9K | $298.6K | $155.6K | $783.5K | |
| Change in Accounts Receivable | -$25.5K | -$69.9K | $49.7K | -$24.1K | -$102.7K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$1.9M | -$1.6M | -$892.8K | -$342.8K | -$946.3K | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | $19.4K | -$15.9K | -$17.8K | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | $42.1K | -$652.5K | $70 | -- | -- | |
| Cash From Financing | -$7.7K | $3.9M | -$16.1K | -$15.4K | $24.4M | |
| Beginning Cash (CF) | $15.5M | $8.4M | $4.9M | $4.2M | $59.5M | |
| Foreign Exchange Rate Adjustment | $120.9K | $39.4K | -$121.9K | $12.1K | -$381.2K | |
| Additions / Reductions | -$1.8M | $2.3M | -$1M | -$346K | $23M | |
| Ending Cash (CF) | $13.9M | $10.7M | $3.8M | $3.8M | $82.2M | |
| Levered Free Cash Flow | -$1.9M | -$1.6M | -$892.8K | -$342.8K | -$946.3K | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$6.9M | -$11.7M | -$5.5M | -$2.1M | -$8.9M | |
| Depreciation & Amoritzation | -- | $4.7K | $53.7K | $54K | $56.2K | |
| Stock-Based Compensation | $698.1K | $689.3K | $854.2K | $618.8K | $2.3M | |
| Change in Accounts Receivable | -$87.1K | -$34.7K | $87.6K | -$15.2K | -$263.7K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$5.8M | -$10.7M | -$5.2M | -$1.4M | -$6.3M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -$5.6K | -$63.8K | -$65.9K | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$1.4M | -- | -$20K | -- | -- | |
| Cash From Financing | $20.5M | $4M | $1.6M | $597K | $63.1M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $14.9M | -$6.5M | -$3.6M | -$762.4K | $57M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$5.8M | -$10.7M | -$5.2M | -$1.4M | -$6.3M | |
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2026-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$11.7M | -$5.5M | -$2.1M | -$8.9M | -- | |
| Depreciation & Amoritzation | $4.7K | $53.7K | $54K | $56.3K | -- | |
| Stock-Based Compensation | $689.3K | $854.2K | $618.9K | $2.3M | -- | |
| Change in Accounts Receivable | -$34.7K | $87.6K | -$15.1K | -$263.7K | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$10.7M | -$5.2M | -$1.4M | -$6.3M | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$5.6K | -$63.8K | -$65.9K | -$33.7K | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$626.2K | -$20K | -- | -$58.2K | -- | |
| Cash From Financing | $4M | $1.6M | $597K | $63.1M | -- | |
| Beginning Cash (CF) | $36M | $26.3M | $18M | $175.9M | -- | |
| Foreign Exchange Rate Adjustment | $203.7K | -$33.9K | $8.3K | $256.6K | -- | |
| Additions / Reductions | -$6.5M | -$3.6M | -$762.5K | $57M | -- | |
| Ending Cash (CF) | $29.8M | $22.6M | $17.3M | $233.2M | -- | |
| Levered Free Cash Flow | -$10.7M | -$5.2M | -$1.4M | -$6.3M | -- | |
Get DRUG Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
DRUG
Sector
P/E ratio
--
23.89x
PEG ratio
-0.46x
-0.01x
P/B ratio
10.85x
1.82x
Price / LTM sales
--
1.60x
Growth Metrics
DRUG
Sector
Revenue growth
--
4.62%
Earnings growth
-230.25%
10.88%
Revenue (5-year growth)
--
6.5%
Earnings forecast
-$0.72
-$0.21
Profitability
DRUG
Sector
Profitability FY 2025
-$55K
$3.5M
Return on invested capital
-24.31%
-31.77%
Return on assets
-23.91%
-27.96%
Return on equity
-24.38%
-37.63%
Earnings Date
Last Earnings Date
Dec
27
Next Earnings Date
Feb
12
Estimated Next Earnings Date
Mar
28
Balance Sheet
DRUG
Sector
Total cash
$59.6M
$26.3M
Short term investments
--
$25.7M
Total assets
$60.7M
$78M
Long term debt
$90.4K
$3.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
72
GLTO alert for Dec 27
Galecto, Inc. [GLTO] is up 16.92% over the past day.
Sell
20
SMX alert for Dec 27
SMX (Security Matters) Plc [SMX] is down 15.76% over the past day.
Sell
11
CDNAF alert for Dec 27
Canadian Tire Corp. Ltd. [CDNAF] is down 10% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
